Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-06

Clinical Trial Update: Effects of Mesna on Homocysteine in Kidney Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the effect of mesna on homocysteine levels in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MESNA (MESNA)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED